Cita APA (7a ed.)
Vickers, J., Cramer, P., Eardley-Patel, R., & Excell, O. (2022). Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing: This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities. Pharmaceutical Technology, 46(8), 31-35.
Cita Chicago Style (17a ed.)
Vickers, Julie, Peter Cramer, Ranna Eardley-Patel, y Oliver Excell. "Overcoming Engineering Challenges to Enable Commercial Scale MRNA Vaccine Manufacturing: This Article Provides an Overview of Solutions to Address Key Challenges Facing Vaccine Developers or CDMOs Wishing to Build Their Own Commercial-scale MRNA Production Facilities." Pharmaceutical Technology 46, no. 8 (2022): 31-35.
Cita MLA (9a ed.)
Vickers, Julie, et al. "Overcoming Engineering Challenges to Enable Commercial Scale MRNA Vaccine Manufacturing: This Article Provides an Overview of Solutions to Address Key Challenges Facing Vaccine Developers or CDMOs Wishing to Build Their Own Commercial-scale MRNA Production Facilities." Pharmaceutical Technology, vol. 46, no. 8, 2022, pp. 31-35.
Precaución: Estas citas no son 100% exactas.